After an observation autism trial in Chile, results revealed successful treatment for autism using medical marijuana extracts.
The act has been reintroduced to remove regulatory barriers that inhibit researchers from obtaining marijuana plans to conduct studies on medical effectiveness and safety.
Evidence from neurobiological research points to cannabinoids as possible therapeutic agents of interest for PTSD, a condition that over 3.5 million people suffer with in the USA alone.
With the right partners and preparations, any cannabis company can get professional analysis.
Western University researchers have found a way to use pharmaceuticals to reverse the negative psychiatric effects of THC.
New York University study investigates the common use of 'Spice' among high school students and high risk of health issues related to synthetic cannabinoid use.
Emerald Health Bioceuticals has created a legal CBD oil alternative for states where medical marijuana has not been legalized.
Neuroscientists have found cannabidiol reduces symptons such as impaired memory in mice when exposed to THC.
University of Oregon economists find a reduction of legally purchased marijuana products moving illegally out of Washington.